{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:36:23Z","timestamp":1787016983030,"version":"build-2736575974"},"reference-count":48,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ZX1903A"],"award-info":[{"award-number":["01ZX1903A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,8,30]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To validate and test the generalisability of the SASKit-ML pipeline, a prepublished feature selection and machine learning pipeline for the prediction of health deterioration after a stroke or pancreatic adenocarcinoma event, by using it to identify biomarkers of health deterioration in chronic disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This is a validation study using a predefined protocol applied to multiple publicly available datasets, including longitudinal data from cohorts with type 2 diabetes (T2D), inflammatory bowel disease (IBD), rheumatoid arthritis (RA) and various cancers. The datasets were chosen to mimic as closely as possible the SASKit cohort, a prospective, longitudinal cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Public data were used from the T2D (77 patients with potential pre-diabetes and 18 controls) and IBD (49 patients with IBD and 12 controls) branches of the Human Microbiome Project (HMP), RA Map (RA-MAP, 92 patients with RA, 22 controls) and The Cancer Genome Atlas (TCGA, 16 cancers).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data integration steps were performed in accordance with the prepublished study protocol, generating features to predict disease outcomes using 10-fold cross-validated random survival forests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>Health deterioration was assessed using disease-specific clinical markers and endpoints across different cohorts. In the HMP-T2D cohort, the worsening of glycated haemoglobin (HbA1c) levels (5.7% or more HbA1c in the blood), fasting plasma glucose (at least 100\u2009mg\/dL) and oral glucose tolerance test (at least 140) results were considered. For the HMP-IBD cohort, a worsening by at least 3 points of a disease-specific severity measure, the \"Simple Clinical Colitis Activity Index\" or \"Harvey-Bradshaw Index\" indicated an event. For the RA-MAP cohort, the outcome was defined as the worsening of the \"Disease Activity Score 28\" or \"Simple Disease Activity Index\" by at least five points, or the worsening of the \"Health Assessment Questionnaire\" score or an increase in the number of swollen\/tender joints were evaluated. Finally, the outcome for all TCGA datasets was the progression-free interval.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Models for the prediction of health deterioration in T2D, IBD, RA and 16 cancers were produced. The T2D (C-index of 0.633 and Integrated Brier Score (IBS) of 0.107) and the RA (C-index of 0.654 and IBS of 0.150) models were modestly predictive. The IBD model was uninformative. TCGA models tended towards modest predictive power.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The SASKit-ML pipeline produces informative and useful features with the power to predict health deterioration in a variety of diseases and cancers; however, this performance is disease-dependent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-088181","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T22:40:29Z","timestamp":1727736029000},"page":"e088181","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Multicohort study testing the generalisability of the SASKit-ML stroke and PDAC prognostic model pipeline to other chronic diseases"],"prefix":"10.1136","volume":"14","author":[{"given":"Daniel","family":"Palmer","sequence":"first","affiliation":[{"name":"Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Henze","sequence":"additional","affiliation":[{"name":"Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany"},{"name":"Department of Internal Medicine II - Hematology, Oncology and Palliative Medicine, Asklepios Hospital Group Harz Mountains, Goslar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Murua Escobar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rostock University Medical Center, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Kowald","sequence":"additional","affiliation":[{"name":"Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4994-9829","authenticated-orcid":false,"given":"Georg","family":"Fuellen","sequence":"additional","affiliation":[{"name":"Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2025120600425921000_14.9.e088181.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039560","article-title":"Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidity and ageing\/cellular senescence (SASKit): protocol for a prospective cohort study","volume":"10","author":"Henze","year":"2020","journal-title":"BMJ Open"},{"key":"2025120600425921000_14.9.e088181.2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2025120600425921000_14.9.e088181.3","doi-asserted-by":"crossref","DOI":"10.1186\/1752-0509-4-164","article-title":"ExprEssence--revealing the essence of differential experimental data in the context of an interaction\/regulation net-work","volume":"4","author":"Warsow","year":"2010","journal-title":"BMC Syst Biol"},{"key":"2025120600425921000_14.9.e088181.4","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780132105"},{"key":"2025120600425921000_14.9.e088181.5","doi-asserted-by":"publisher","DOI":"10.1214\/08-AOAS169"},{"key":"2025120600425921000_14.9.e088181.6","doi-asserted-by":"crossref","DOI":"10.3390\/genes10030238","article-title":"Challenges in the Integration of Omics and Non-Omics Data","volume":"10","author":"L\u00f3pez de Maturana","year":"2019","journal-title":"Genes (Basel)"},{"key":"2025120600425921000_14.9.e088181.7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/bib\/bbz158","article-title":"Toward a gold standard for benchmarking gene set enrichment analysis","volume":"22","author":"Geistlinger","year":"2021","journal-title":"Brief Bioinform"},{"key":"2025120600425921000_14.9.e088181.8","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa167","article-title":"Large-scale benchmark study of survival prediction methods using multi-omics data","volume":"22","author":"Herrmann","year":"2021","journal-title":"Brief Bioinform"},{"key":"2025120600425921000_14.9.e088181.9","doi-asserted-by":"crossref","first-page":"111327","DOI":"10.1016\/j.biopha.2021.111327","article-title":"Evidence and perspectives of cell senescence in neurodegenerative diseases","volume":"137","author":"Si","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2025120600425921000_14.9.e088181.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00624-2"},{"key":"2025120600425921000_14.9.e088181.11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133668","article-title":"The senescence-associated secretome as an indicator of age and medical risk","volume":"5","author":"Schafer","year":"2020","journal-title":"JCI Insight"},{"key":"2025120600425921000_14.9.e088181.12","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.40934","article-title":"Senescence Signature in Skin Biopsies From Systemic Sclerosis Patients Treated With Senolytic Therapy: Potential Predictor of Clinical Response?","volume":"71","author":"Martyanov","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025120600425921000_14.9.e088181.13","doi-asserted-by":"crossref","first-page":"D734","DOI":"10.1093\/nar\/gkaa996","article-title":"HMPDACC: a Human Microbiome Project Multi-omic data resource","volume":"49","author":"Creasy","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2025120600425921000_14.9.e088181.14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","article-title":"The Integrative Human Microbiome Project","volume":"569","author":"Proctor","year":"2019","journal-title":"Nature New Biol"},{"key":"2025120600425921000_14.9.e088181.15","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab136","article-title":"Role of Cellular Senescence in Type II Diabetes","volume":"162","author":"Narasimhan","year":"2021","journal-title":"Endocrinology"},{"key":"2025120600425921000_14.9.e088181.16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24129810","article-title":"Cellular Senescence, Inflammation, and Cancer in the Gastrointestinal Tract","volume":"24","author":"Choi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025120600425921000_14.9.e088181.17","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaa017","article-title":"RA-map: building a state-of-the-art interactive knowledge base for rheumatoid arthritis","volume":"2020","author":"Singh","year":"2020","journal-title":"Database (Oxford)"},{"key":"2025120600425921000_14.9.e088181.18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41597-022-01264-y","article-title":"RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients","volume":"9","author":"Isaacs","year":"2022","journal-title":"Sci Data"},{"key":"2025120600425921000_14.9.e088181.19","unstructured":"TCGA Research Network . Data from: The cancer genome atlas,TCGA. 2019. Available: https:\/\/www.cancer.gov\/ccg\/research\/genome-sequencing\/tcga"},{"key":"2025120600425921000_14.9.e088181.20","first-page":"S67","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36 Suppl 1","year":"2013","journal-title":"Diabetes Care"},{"key":"2025120600425921000_14.9.e088181.21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s10620-017-4549-3","article-title":"Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab","volume":"62","author":"Allegretti","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2025120600425921000_14.9.e088181.22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4253\/wjge.v7.i17.1233","article-title":"Use of blood based biomarkers in the evaluation of Crohn\u2019s disease and ulcerative colitis","volume":"7","author":"Barnes","year":"2015","journal-title":"World J Gastrointest Endosc"},{"key":"2025120600425921000_14.9.e088181.23","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkz002","article-title":"Predicting disease progression and poor outcomes in patients with moderately active rheumatoid arthritis: a systematic review","volume":"3","author":"Edwards","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"2025120600425921000_14.9.e088181.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.02.052"},{"key":"2025120600425921000_14.9.e088181.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2025120600425921000_14.9.e088181.26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.27"},{"key":"2025120600425921000_14.9.e088181.27","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAC1000"},{"key":"2025120600425921000_14.9.e088181.28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz446"},{"key":"2025120600425921000_14.9.e088181.29","doi-asserted-by":"publisher","DOI":"10.1198\/jasa.2009.tm08622"},{"key":"2025120600425921000_14.9.e088181.30","article-title":"Association of Serum High Sensitivity C-Reactive Protein With Pre-diabetes in Rural Population: A Two-Year Cross-Sectional Study","volume":"13","author":"Ghule","year":"2021","journal-title":"Cureus"},{"key":"2025120600425921000_14.9.e088181.31","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7190828","article-title":"Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein","volume":"2020","author":"Szu\u0142drzy\u0144ski","year":"2020","journal-title":"Dis Markers"},{"key":"2025120600425921000_14.9.e088181.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037932","article-title":"Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA","volume":"7","author":"Hotte","year":"2012","journal-title":"PLoS One"},{"key":"2025120600425921000_14.9.e088181.33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JIR.S236262","article-title":"Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNF\u03b1 Non-Response IBD Patients","volume":"13","author":"Liu","year":"2020","journal-title":"J Inflamm Res"},{"key":"2025120600425921000_14.9.e088181.34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/ibd\/izaa217","article-title":"Tissue-based Gene Expression as Potential Biomarkers for IBD Course","volume":"26","author":"Haberman","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2025120600425921000_14.9.e088181.35","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3748\/wjg.v26.i39.5983","article-title":"Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses","volume":"26","author":"Shi","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2025120600425921000_14.9.e088181.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812874106"},{"key":"2025120600425921000_14.9.e088181.37","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001812"},{"key":"2025120600425921000_14.9.e088181.38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/01616412.2021.1948766","article-title":"Circulating granulocyte colony-stimulating factor and functional outcome after ischemic stroke: an observational study","volume":"43","author":"Wall","year":"2021","journal-title":"Neurol Res"},{"key":"2025120600425921000_14.9.e088181.39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1159\/000512367","article-title":"The Protective and Reparative Role of Colony-Stimulating Factors in the Brain with Cerebral Ischemia\/Reperfusion Injury","volume":"111","author":"Patel","year":"2021","journal-title":"Neuroendocrinology"},{"key":"2025120600425921000_14.9.e088181.40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molimm.2018.08.002","article-title":"Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke","volume":"101","author":"He","year":"2018","journal-title":"Mol Immunol"},{"key":"2025120600425921000_14.9.e088181.41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104501","article-title":"The link between rheumatic disorders and inborn errors of immunity","volume":"90","author":"Sogkas","year":"2023","journal-title":"EBioMedicine"},{"key":"2025120600425921000_14.9.e088181.42","first-page":"30","article-title":"Identification of potential biomarkers for differential diagnosis between rheumatoid arthritis and osteoarthritis via integrative genome\u2011wide gene expression profiling analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"Mol Med Rep"},{"key":"2025120600425921000_14.9.e088181.43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jcla.21908","article-title":"The Association Between Neutrophil\/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis","volume":"30","author":"Mercan","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"2025120600425921000_14.9.e088181.44","doi-asserted-by":"crossref","DOI":"10.1186\/ar4540","article-title":"Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study","volume":"16","author":"Innala","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025120600425921000_14.9.e088181.45","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13037","article-title":"Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis","volume":"49","author":"Erre","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"2025120600425921000_14.9.e088181.46","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1077"},{"key":"2025120600425921000_14.9.e088181.47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.881633","article-title":"A Genome-Wide Association Study of Prediabetes Status Change","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025120600425921000_14.9.e088181.48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.compbiomed.2017.10.021","article-title":"Comparison of variable selection methods for high-dimensional survival data with competing events","volume":"91","author":"Gilhodes","year":"2017","journal-title":"Comput Biol Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-088181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:43:11Z","timestamp":1765010591000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-088181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,30]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bmjopen-2024-088181"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-088181","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}